Second phase III trial of forigerimod for systemic lupus erythematosus.

Trial Profile

Second phase III trial of forigerimod for systemic lupus erythematosus.

Planning
Phase of Trial: Phase III

Latest Information Update: 30 Apr 2015

At a glance

  • Drugs Forigerimod (Primary)
  • Indications Systemic lupus erythematosus
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 30 Apr 2015 According to ImmuPharma media release, agreement was signed with Simbec-Orion an international clinical research organisation to under take crucial Phase III clinical trial.
    • 13 Aug 2013 New trial record
    • 12 Aug 2013 This is one of two trials in the phase III programme, according to an ImmuPharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top